Showing 1 - 13 results of 13 for search 'John Souglakos', query time: 0.05s Refine Results
  1. 1
    How close are we to customizing chemotherapy in early non-small cell lung cancer?

    How close are we to customizing chemotherapy in early non-small cell lung cancer? by Georgios Ioannidis, Vassilis Georgoulias, John Souglakos

    Published 2011-07-01
    Get full text
    Article
  2. 2
    Case report: a rare case of diffusely metastatic BRAF V600E-mutated colorectal cancer with concomitant infiltration of the skin and parotid gland

    Case report: a rare case of diffusely metastatic BRAF V600E-mutated colorectal cancer with concomitant infiltration of the skin and parotid gland by Aristeidis E. Boukouris, Ioannis Kokkinakis, Elias Drakos, Maria Sfakianaki, Maria Tzardi, Dimitrios Mavroudis, Dimitrios Mavroudis, John Souglakos, John Souglakos

    Published 2025-01-01
    Get full text
    Article
  3. 3
    Deep Radiotranscriptomics of Non-Small Cell Lung Carcinoma for Assessing Molecular and Histology Subtypes with a Data-Driven Analysis

    Deep Radiotranscriptomics of Non-Small Cell Lung Carcinoma for Assessing Molecular and Histology Subtypes with a Data-Driven Analysis by Eleftherios Trivizakis, John Souglakos, Apostolos Karantanas, Kostas Marias

    Published 2021-12-01
    Get full text
    Article
  4. 4
    Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signature

    Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signature by Eleftherios Trivizakis, Nikoletta-Maria Koutroumpa, John Souglakos, Apostolos Karantanas, Michalis Zervakis, Kostas Marias

    Published 2023-12-01
    Get full text
    Article
  5. 5
    KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer.

    KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer. by Aristea Kalikaki, Helen Politaki, John Souglakos, Stella Apostolaki, Elisavet Papadimitraki, Nefeli Georgoulia, Maria Tzardi, Dimitris Mavroudis, Vassilis Georgoulias, Alexandra Voutsina

    Published 2014-01-01
    Get full text
    Article
  6. 6
    Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide.

    Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplati... by Niki Karachaliou, Chara Papadaki, Eleni Lagoudaki, Maria Trypaki, Maria Sfakianaki, Anastasios Koutsopoulos, Dimitris Mavroudis, Efstathios Stathopoulos, Vassilis Georgoulias, John Souglakos

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Novel Prognostic Biomarkers in Metastatic and Locally Advanced Colorectal Cancer: Micronuclei Frequency and Telomerase Activity in Peripheral Blood Lymphocytes

    Novel Prognostic Biomarkers in Metastatic and Locally Advanced Colorectal Cancer: Micronuclei Frequency and Telomerase Activity in Peripheral Blood Lymphocytes by Taxiarchis Konstantinos Nikolouzakis, Elena Vakonaki, Polychronis D. Stivaktakis, Athanasios Alegakis, Aikaterini Berdiaki, Nikolaos Razos, John Souglakos, Aristidis Tsatsakis, John Tsiaoussis

    Published 2021-06-01
    Get full text
    Article
  8. 8
    Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.

    Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer. by Ippokratis Messaritakis, Maria Stogiannitsi, Asimina Koulouridi, Maria Sfakianaki, Alexandra Voutsina, Afroditi Sotiriou, Elias Athanasakis, Evangelos Xynos, Dimitris Mavroudis, Maria Tzardi, John Souglakos

    Published 2018-01-01
    Get full text
    Article
  9. 9
    Achieving a Textbook Outcome in Colon Cancer Surgery Is Associated with Improved Long-Term Survival

    Achieving a Textbook Outcome in Colon Cancer Surgery Is Associated with Improved Long-Term Survival by Dimitrios K. Manatakis, Maria Tzardi, John Souglakos, John Tsiaoussis, Christos Agalianos, Ioannis D. Kyriazanos, George Pechlivanides, Athanasios Kordelas, Nikolaos Tasis, Nikolaos Gouvas, Evaghelos Xynos

    Published 2023-02-01
    Get full text
    Article
  10. 10
    BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome.

    BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients'... by Zacharenia Saridaki, Maria Tzardi, Maria Sfakianaki, Chara Papadaki, Alexandra Voutsina, Aristea Kalykaki, Ippokratis Messaritakis, Kyriakos Mpananis, Dimitris Mavroudis, Efstathios Stathopoulos, Vassilis Georgoulias, John Souglakos

    Published 2013-01-01
    Get full text
    Article
  11. 11
    Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients.

    Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients. by Zacharenia Saridaki, Maria Tzardi, Chara Papadaki, Maria Sfakianaki, Fraga Pega, Aristea Kalikaki, Eleftheria Tsakalaki, Maria Trypaki, Ippokratis Messaritakis, Efstathios Stathopoulos, Dimitris Mavroudis, Vassilis Georgoulias, John Souglakos

    Published 2011-01-01
    Get full text
    Article
  12. 12
    Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.

    Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients. by Ioannis Boukovinas, Chara Papadaki, Pedro Mendez, Miquel Taron, Dimitris Mavroudis, Anastasios Koutsopoulos, Maria Sanchez-Ronco, Jose Javier Sanchez, Maria Trypaki, Eustathios Staphopoulos, Vassilis Georgoulias, Rafael Rosell, John Souglakos

    Published 2008-01-01
    Get full text
    Article
  13. 13
    Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis

    Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis by Jun Yin, Shaheenah Dawood, Romain Cohen, Jeff Meyers, John Zalcberg, Takayuki Yoshino, Matthew Seymour, Tim Maughan, Leonard Saltz, Eric Van Cutsem, Alan Venook, Hans-Joachim Schmoll, Richard Goldberg, Paulo Hoff, J. Randolph Hecht, Herbert Hurwitz, Cornelis Punt, Eduard Diaz Rubio, Miriam Koopman, Chiara Cremolini, Volker Heinemann, Christophe Tournigard, Carsten Bokemeyer, Charles Fuchs, Niall Tebbutt, John Souglakos, Jean-Yves Doulliard, Fairooz Kabbinavar, Benoist Chibaudel, Aimery de Gramont, Qian Shi, Axel Grothey, Richard Adams

    Published 2021-06-01
    Get full text
    Article

Search Tools: